A detailed history of Meiji Yasuda Life Insurance CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Meiji Yasuda Life Insurance CO holds 6,972 shares of EXAS stock, worth $402,981. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,972
Previous 6,972 -0.0%
Holding current value
$402,981
Previous $294,000 61.22%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $15,795 - $23,952
-252 Reduced 3.49%
6,972 $655,000
Q1 2023

May 10, 2023

BUY
$47.19 - $70.77 $15,525 - $23,283
329 Added 4.77%
7,224 $490,000
Q1 2022

May 17, 2022

BUY
$57.56 - $82.54 $18,764 - $26,908
326 Added 4.96%
6,895 $482,000
Q4 2020

Feb 12, 2021

SELL
$99.61 - $142.12 $82,775 - $118,101
-831 Reduced 11.23%
6,569 $870,000
Q2 2020

Aug 13, 2020

BUY
$55.75 - $92.75 $412,550 - $686,350
7,400 New
7,400 $643,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Meiji Yasuda Life Insurance CO Portfolio

Follow Meiji Yasuda Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.